Organic anion transporter 3 inhibitors as potential novel antihypertensives

Pharmacological Research

Volumn 58, Issue 5-6, 2008, Pages 257-261

  Eraly, Satish A ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Alternating access; Antihypertensive; Blood pressure; Hypertension; Oat3; Oat3 inhibitor; Organic anion transporter; Trans inhibition

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLIC AMP; CYCLIC GMP; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; EOSIN; FLUORESCEIN DERIVATIVE; ORGANIC ANION TRANSPORTER 3; ORGANIC ANION TRANSPORTER 3 INHIBITOR; PROBENECID; PROSTAGLANDIN E2; RENIN; SODIUM ION; UNCLASSIFIED DRUG;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR EFFECT; CHEMICAL STRUCTURE; CORONARY ARTERY DISEASE; DRUG EFFECT; DRUG INDICATION; DRUG POTENCY; DRUG TARGETING; HUMAN; HYPERTENSION; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE FUNCTION; KNOCKOUT MOUSE; NONHUMAN; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROTEINURIA; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SODIUM BALANCE; VASCULAR SMOOTH MUSCLE;

ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; EOSINE YELLOWISH-(YS); HUMANS; ORGANIC ANION TRANSPORTERS, SODIUM-INDEPENDENT; PROBENECID;

EID: 56649123300     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2008.09.013     Document Type: Review

References (30)

1. Wright S.H., and Dantzler W.H. Molecular cellular physiology of renal organic cation and anion transport. Physiol Rev 84 (2004) 987-1049
2. Eraly S.A., Bush K.T., Sampogna R.V., Bhatnagar V., and Nigam S.K. The molecular pharmacology of organic anion transporters: from DNA to FDA?. Mol Pharmacol 65 (2004) 479-487
3. Eraly S.A., Vallon V., Vaughn D.A., Gangoiti J.A., Richter K., Nagle M., et al. Decreased renal organic anion secretion and plasma accumulation of endogenous organic anions in OAT1 knockout mice. J Biol Chem 281 epub 2005 (2006) 5072-5083
4. Vallon V., Eraly S.A., Wikoff W.R., Rieg T., Kaler G., Truong D.M., et al. Organic anion transporter 3 contributes to the regulation of blood pressure. J Am Soc Nephrol (2008) May 28 [Epub ahead of print]
5. Burckhardt B.C., and Burckhardt G. Transport of organic anions across the basolateral membrane of proximal tubule cells. Rev Physiol Biochem Pharmacol 146 (2003) 95-158
6. Eraly S.A., Vallon V., Rieg T., Gangoiti J.A., Wikoff W.R., Siuzdak G., et al. Multiple organic anion transporters contribute to net renal excretion of uric acid. Physiol Genomics 33 (2008) 180-192
7. Vanwert A.L., and Sweet D.H. Impaired clearance of methotrexate in organic anion transporter 3 (Slc22a8) knockout mice: a gender specific impact of reduced folates. Pharm Res 25 (2008) 453-462
8. Vallon V., Rieg T., Ahn S.-Y., Wu W., Eraly S.A., and Nigam S.K. Overlapping in vitro and in vivo specificities of the organic anion transporters OAT1 and OAT3 for loop and thiazide diuretics. Am J Physiol Renal Physiol (2008) January 23 [Epub ahead of print]
9. VanWert A.L., Bailey R.M., and Sweet DH. Organic anion transporter 3 (Oat3/Slc22a8) knockout mice exhibit altered clearance and distribution of penicillin G. Am J Physiol Renal Physiol 293 (2007) F1332-1341 doi:10.1152/ajprenal.00319.2007
10. Sykes D., Sweet D.H., Lowes S., Nigam S.K., Pritchard J.B., and Miller D.S. Organic anion transport in choroid plexus from wild-type and organic anion transporter 3 (Slc22a8)-null mice. Am J Physiol Renal Physiol 286 (2004) F972-978 Epub 2003 December 2023
11. Sweet D.H., Miller D.S., Pritchard J.B., Fujiwara Y., Beier D.R., and Nigam S.K. Impaired organic anion transport in kidney and choroid plexus of organic anion transporter 3 (Oat3 [Slc22a8]) knockout mice. J Biol Chem 277 (2002) 26934-26943
12. Jonker J.W., Wagenaar E., Mol C.A.A.M., Buitelaar M., Koepsell H., Smit J.W., et al. Reduced hepatic uptake and intestinal excretion of organic cations in mice with a targeted disruption of the organic cation transporter 1 (Oct1 [Slc22a1]) gene. Mol Cell Biol 21 (2001) 5471-5477
13. Jonker J.W., Wagenaar E., Van Eijl S., and Schinkel A.H. Deficiency in the organic cation transporters 1 and 2 (Oct1/Oct2 [Slc22a1/Slc22a2]) in mice abolishes renal secretion of organic cations. Mol Cell Biol 23 (2003) 7902-7908
14. Zwart R., Verhaagh S., Buitelaar M., Popp-Snijders C., and Barlow D.P. Impaired activity of the extraneuronal monoamine transporter system known as uptake-2 in Orct3/Slc22a3-Deficient Mice. Mol Cell Biol 21 (2001) 4188-4196
15. Genest J. Progress in hypertension research: 1900-2000. Hypertension 38 (2001) e13-e18
16. Bahn A., Ljubojevic M., Lorenz H., Schultz C., Ghebremedhin E., Ugele B., et al. Murine renal organic anion transporter 1 (mOAT1) and organic anion transporter 3 (mOAT3) facilitate the transport of neuroactive tryptophan metabolites. Am J Physiol Cell Physiol 289 (2005) C1075
17. Nilwarangkoon S., Anzai N., Shiraya K., Yu E., Islam R., Cha S.H., et al. Role of mouse organic anion transporter 3 (mOat3) as a basolateral prostaglandin E2 transport pathway. J Pharmacol Sci 103 (2007) 48-55
18. Persson A.E.G., Ollerstam A., Liu R., and Brown R. Mechanisms for macula densa cell release of renin. Acta Physiol Scand 181 (2004) 471-474
19. Schnermann J. Cyclooxygenase-2 and macula densa control of renin secretion. Nephrol Dial Transplant 16 (2001) 1735-1738 doi:10.1093/ndt/16.9.1735
20. Kobayashi Y., Ohshiro N., Tsuchiya A., Kohyama N., Ohbayashi M., and Yamamoto T. Renal transport of organic compounds mediated by mouse organic anion transporter 3 (moat3): further substrate specificity of moat3. Drug Metab Dispos 32 (2004) 479-483 doi:10.1124/dmd.32.5.479
21. Narumiya S., Sugimoto Y., and Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev 79 (1999) 1193-1226
22. Feil R., Lohmann S.M., de Jonge H., Walter U., and Hofmann F. Cyclic GMP-dependent protein kinases and the cardiovascular system: insights from genetically modified mice. Circ Res 93 (2003) 907-916
23. Witte K., and Lemmer B. Signal transduction in animal models of normotension and hypertension. Ann NY Acad Sci 783 (1996) 71-83
24. Yamamoto H., Tsuruoka S., Ioka T., Ando H., Ito C., Akimoto T., et al. Indoxyl sulfate stimulates proliferation of rat vascular smooth muscle cells. Kidney Int 69 (2006) 1780-1785
25. Haylor J., Lote C.J., and Towers J.D. Tubular mechanisms determining the urinary excretion of tritiated prostaglandin E2 in the anaesthetized rat. J Physiol 403 (1988) 1-14
26. Lemieux M.J., Huang Y., and Wang D.N. The structural basis of substrate translocation by the Escherichia coli glycerol-3-phosphate transporter: a member of the major facilitator superfamily. Curr Opin Struct Biol 14 (2004) 405-412
27. Apiwattanakul N., Sekine T., Chairoungdua A., Kanai Y., Nakajima N., Sophasan S., et al. Transport properties of nonsteroidal anti-inflammatory drugs by organic anion transporter 1 expressed in xenopus laevis oocytes. Mol Pharmacol 55 (1999) 847-854
28. Bakhiya A., Bahn A., Burckhardt G., and Wolff N. Human organic anion transporter 3 (hOAT3) can operate as an exchanger and mediate secretory urate flux. Cell Physiol Biochem 13 (2003) 249-256
29. Dantzler W.H., Evans K.K., and Wright S.H. Kinetics of interactions of para-aminohippurate, probenecid, cysteine conjugates and N-acetyl cysteine conjugates with basolateral organic anion transporter in isolated rabbit proximal renal tubules. J Pharmacol Exp Ther 272 (1995) 663-672
30. Truong D.M., Kaler G., Khandelwal A., Swaan P.W., and Nigam S.K. Multilevel analysis of organic anion transporters 1,3, and 6 reveals major differences in structural determinants of antiviral discrimination. J Biol Chem 283 (2008) 8654-8663